[Rinsho ketsueki] The Japanese journal of clinical hematology

Publications

volume 65, number 6, 2024

Takahiro Suzuki
[Overview]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (6) (2024)
Shinnosuke Tokuda, Koshiro Sakamoto, Makiko Mizuguchi, Yasunobu Okamoto, Hikaru Yagi, Kumiko Kagawa, Hironobu Shibata, Hideko Endo, Shuji Ozaki
[Multiple myeloma with t (8;14) and t (11;14) and extramedullary infiltration of multiple organs]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (6) (2024)
Hiroshi Kawabata
[Diagnosis and treatment of iron deficiency anemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (6) (2024)
Naoshi Obara
[Current trends in the treatment of aplastic anemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (6) (2024)
Hiroshi Tsujimoto, Norimitsu Inoue
[Coagulation and complement crosstalk: molecular mechanisms of complement-mediated diseases]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (6) (2024)
Eriko Morishita
[Overview]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (6) (2024)
Daisuke Ennishi
[Cancer genomic panels for lymphoid malignancies]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (6) (2024)
Hiroshi Kawabata
[Diagnosis and treatment of iron deficiency anemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (6) (2024)
Hiroshi Tsujimoto, Norimitsu Inoue
[Coagulation and complement crosstalk: molecular mechanisms of complement-mediated diseases]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (6) (2024)
Tomoyasu Jo, Yasuyuki Arai
[CAR T-cell therapy for malignant lymphoma]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (6) (2024)
Misayo Shimizu, Yuri Tsuboi, Akihiro Kuroda, Masanori Seki, Atsushi Shinagawa
[TCL1-family negative T-cell prolymphocytic leukemia with rapid progression of extranodal disease despite a normal white blood cell count]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (6) (2024)
Hidemi Toyoda, Chitose Ogawa, Ayumu Arakawa, Junko Yamanaka, Shinji Mochizuki, Akiko M Saito, Toshiki I Saito, Hiroaki Goto, Keizo Horibe
[Experience with an international study on standard-risk relapsed childhood acute lymphoblastic leukemia (IntReALL SR 2010 study) in Japan]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (6) (2024)
Masaki Ri
[Novel therapies for multiple myeloma]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (6) (2024)
Ryosuke Uchibori
[Challenges and strategies for improving efficacy in CAR-T therapy]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (6) (2024)
Ryosuke Uchibori
[Challenges and strategies for improving efficacy in CAR-T therapy]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (6) (2024)
Rintaro Fujimoto, Tsuyoshi Kamae, Kimimori Kamijo, Masato Yasumi, Takahiro Karasuno
[Successful remission induction with reduced-dose all-trans retinoic acid for acute promyelocytic leukemia complicated by COVID-19]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (6) (2024)
Satoshi Higasa
[Novel treatment strategies for acquired hemophilia A]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (6) (2024)
Momoko Nishiko
[Overview]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (6) (2024)
Misayo Shimizu, Yuri Tsuboi, Akihiro Kuroda, Masanori Seki, Atsushi Shinagawa
[TCL1-family negative T-cell prolymphocytic leukemia with rapid progression of extranodal disease despite a normal white blood cell count]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (6) (2024)
Hideho Wada
[Cold agglutinin disease: pathology, diagnosis, and treatment]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (6) (2024)
Masahito Uchihara, Masayuki Kubo, Masanori Matsumoto
[Advances in the treatment of thrombotic thrombocytopenic purpura]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (6) (2024)

volume 65, number 7, 2024

Masakazu Mori, Yuki Goto, Ryuichiro Hiyama, Ryo Ueda, Risa Hashida, Kyoko Itakusu, Kyosuke Saeki, Koichi Nakase, Yuichiro Nawa
[Durable remission with lenalidomide in a patient with early relapse of adult T-cell leukemia/lymphoma after cord blood transplantation]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (7) (2024)
Kenichi Asano
[Role and origin of neutrophil-like regulatory monocytes and comparison with neutrophils]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (7) (2024)
Shoji Saito
[Current state and future prospects of CAR T-cell therapy for myeloid malignancies]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (7) (2024)
Fuminari Fujii, Toshiki Terao, Hisakazu Nishimori, Kentaro Fujii, Toshihiko Matsuo, Tadashi Yoshino, Hiroko Ueda, Tadashi Oyama, Akifumi Matsumura, Kaho Kondo, Chisato Matsubara, Kanako Fujiwara, Keisuke Seike, Hideaki Fujiwara, Noboru Asada, Daisuke Ennishi, Keiko Fujii, Nobuharu Fujii, Ken-Ichi Matsuoka, Yoshinobu Maeda
[Relapsed primary central nervous system lymphoma treated with CD19 chimeric antigen receptor T-cell therapy and allogeneic hematopoietic stem cell transplantation]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (7) (2024)
Masakazu Mori, Yuki Goto, Ryuichiro Hiyama, Ryo Ueda, Risa Hashida, Kyoko Itakusu, Kyosuke Saeki, Koichi Nakase, Yuichiro Nawa
[Durable remission with lenalidomide in a patient with early relapse of adult T-cell leukemia/lymphoma after cord blood transplantation]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (7) (2024)
Satoshi Wakita
[Appropriate use of the ELN guidelines based on results of real-world genetic analysis in Japanese patients with AML]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (7) (2024)
Nobuhiro Tsukada, Moe Yogo, Kodai Kunisada, Yuki Oda, Tomomi Takei, Kota Sato, Mizuki Ogura, Taku Kikuchi, Yu Abe, Kenshi Suzuki, Tadao Ishida
[Retrospective analysis of allogeneic hematopoietic stem cell transplantation for multiple myeloma after myeloablative conditioning with 8 Gy of total body irradiation]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (7) (2024)
Goro Sashida
[Infection stress and a driver mutation interact to promote transformation to hematological malignancies]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (7) (2024)
Itaru Kato
[Development of dual-targeted CAR T-cell therapy]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (7) (2024)
Chihaya Imai
[Current state and future prospects of off-the-shelf allogeneic CAR NK therapy]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (7) (2024)
Yuichi Ishikawa
[Current status and challenges of AML treatment with FLT3 inhibitors]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (7) (2024)
Haruko Tashiro
[CAR T-cell therapy for T cell malignancies: challenges and recent advances]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (7) (2024)
Kenichi Sakamoto, Shigeki Yagyu
[Adoptive cell therapy for solid tumors]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (7) (2024)
Yozo Nakazawa
[Overview]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (7) (2024)

volume 65, number 8, 2024

Daiki Komata, Mutsumi Takahata, Yoshinori Makino, Takashi Ishio, Hiroshi Iwasaki, Shin Ichihara, Masumi Tsuda, Shinya Tanaka, Makoto Ibata
[Histiocytic sarcoma derived from the same origin as splenic marginal zone lymphoma revealed by exome analysis]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (8) (2024)
Shuichi Shirane
[Budd-Chiari syndrome and JAK2 gene mutation]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (8) (2024)
Kenichi Yoshida
[Clonal evolution in myeloproliferative neoplasms]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (8) (2024)
Miyoko O Watanabe
[Building a future society that helps female scientists and physicians thrive]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (8) (2024)
Akira Ishiguro, Toru Uchiyama, Atsushi Sakamoto, Shinji Kunishima
[Developments of high-throughput sequencing-based diagnosis of congenital thrombocytopenia/platelet disorders in a registry study]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (8) (2024)
Yuta Suzuki, Toshio Kitawaki, Yasuyuki Arai, Shunsaku Nakagawa, Kazuhisa Chonabayashi, Yasuhito Nannya, Kouhei Yamashita, Seishi Ogawa, Akifumi Takaori-Kondo
[Concentration of gilteritinib in the cerebrospinal fluid of a patient with relapsed FLT3-ITD positive acute myeloid leukemia with optic nerve involvement]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (8) (2024)
Wakana Takahashi, Tatsuya Hatada, Chizuru Saito, Ryoichi Murata, Mikio Ueda, Toshihiro Miyamoto
[Development of Lomentospora prolificans infection during induction therapy with venetoclax and azacitidine for acute myeloid leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (8) (2024)
Tadashi Matsushita
[Biology of von Willebrand factor and pathogenesis of von Willebrand disease]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (8) (2024)
Shuichi Ota
[Treatment strategies for low-risk polycythemia vera]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (8) (2024)
Mariko Eguchi
[Supporting career development of female physicians and researchers]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (8) (2024)
Masafumi Ito
[Recent advances in bone marrow pathology for myeloproliferative neoplasms diagnosis]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (8) (2024)
Yuta Suzuki, Toshio Kitawaki, Yasuyuki Arai, Shunsaku Nakagawa, Kazuhisa Chonabayashi, Yasuhito Nannya, Kouhei Yamashita, Seishi Ogawa, Akifumi Takaori-Kondo
[Concentration of gilteritinib in the cerebrospinal fluid of a patient with relapsed FLT3-ITD positive acute myeloid leukemia with optic nerve involvement]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (8) (2024)
Hiroshi Kosugi
[JAK inhibitors for myelofibrosis: ruxolitinib and momelotinib]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (8) (2024)
Hideshige Seki, Megumi Yasunaga, Ken Morita, Mineo Kurokawa
[Clostridioides difficile infection diagnosed by nucleic acid amplification test in a patient with Epstein-Barr Virus-related T-cell lymphoproliferative disorder]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (8) (2024)
Shuichi Shirane
[Budd-Chiari syndrome and JAK2 gene mutation]. [Rinsho ketsueki] The Japanese journal of clinical hematology 65 (8) (2024)